Occurrence of multiple myeloma 13 years after Hodgkin’s disease: chance or consequence?
Letter to the Editor
First Online:
Received:
Accepted:
- 77 Downloads
- 2 Citations
Keywords
Multiple Myeloma Acute Myeloid Leukemia Osteolytic Lesion Secondary Malignancy Secondary Cancer
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Notes
Acknowledgements
We thank the internal reviewer in our institution. We greatly appreciate Prof. Dr. R. Mertelsmann’s continuous support, his valuable suggestions, and critical reading of the manuscript.
References
- 1.Abrahamsen AF, Andersen A, Nome O, Jacobsen AB, Holte H, Abrahamsen AJ, Kvaloy S (2002) Long-term risk of second malignancy after treatment of Hodgkin’s disease: the influence of treatment, age and follow-up time. Ann Oncol 13:1786–1791CrossRefPubMedGoogle Scholar
- 2.Cawley JC, Goldstone AH, Arno J, Rees JHK, Grant A (1974) Myeloma in a case of Hodgkin’s disease. Acta Haematol 52:349–355PubMedGoogle Scholar
- 3.Diehl V, Franklin J, Pfreundschuh M, Lathan B, Paulus U, Hasenclever D, Tesch H, Herrmann R, Dorken B, Muller-Hermelink HK, Duhmke E, Loeffler M, German Hodgkin’s Lymphoma Study Group (2003) Standard and increased-dose BEACOPP chemotherapy compared with COPP–ABVD for advanced Hodgkin’s disease. N Engl J Med 348:2386–2395CrossRefPubMedGoogle Scholar
- 4.Dorn GW, Baldwin JG Jr (1984) Rapid development of myeloma in a patient with Hodgkin’s disease. J S C Med Assoc 80:599–600PubMedGoogle Scholar
- 5.Gherlinzoni F, Cavo M, Pileri S, Rivano MT, Boriani S, Biagini R, Emiliani E (1986) Solitary plasmacytoma of the bone in a case of Hodgkin’s disease. Acta Haematol 76:178–180PubMedGoogle Scholar
- 6.Ibbotson RM, Revell PA, Molland EA, Minton MJ (1977) The simultaneous presentation of Hodgkin’s disease and myeloma. Postgrad Med J 53:52–53PubMedGoogle Scholar
- 7.Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ (1996) Second malignancies after treatment for laparotomy staged IA–IIIB Hodgkin’s disease: long-term analysis of risk factors and outcome. Blood 87:3625–3632PubMedGoogle Scholar
- 8.Müller AMS, Ihorst G, Mertelsmann R, Engelhardt M (2005) Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 84:1–12CrossRefPubMedGoogle Scholar
- 9.Munker R, Grützner S, Hiller E, Aydemir Ü, Enne W, Dietzfelbinger H, Busch M, Haas R, Emmerich B, Schmidt M, Dühmke E, Hölzel D, Wilmanns W (1999) Second malignancies after Hodgkin’s disease: the Munich experience. Ann Hematol 78:544–554CrossRefPubMedGoogle Scholar
- 10.Ng AK, Bernardo MVP, Weller E, Backstrand K, Silver B, Marcus KC, Tarbell NJ, Stevenson MA, Friedberg JW, Mauch PM (2002) Second malignancy after Hodgkin’s disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 100:1989–1996CrossRefPubMedGoogle Scholar
- 11.Sacks PV, Tavassoli M, Eastlund DT (1976) Simultaneous occurrence of myeloma and Hodgkin’s disease. Acta Haematol 55:118–122PubMedCrossRefGoogle Scholar
- 12.van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EHM, van Heerde P, Somers R (1994) Second cancer risk following Hodgkin’s disease: a 20-year follow-up study. J Clin Oncol 12:312–325PubMedGoogle Scholar
- 13.van Leeuwen FE, Klokman WJ, van’t Veer MB, Hagenbeek A, Krol ADG, Vetter UAO, Shaapveld M, van Heerde P, Burgers JMV, Somers R, Aleman BMP (2000) Long-term risk of second malignancy in survivors of Hodgkin’s disease treated during adolescence or young adulthood. J Clin Oncol 18:487–497PubMedGoogle Scholar
- 14.Zarate-Osorno A, Medeiros LJ, Longo DL, Jaffe ES (1992) Non-Hodgkin’s lymphoma arising in patients successfully treated for Hodgkin’s disease. Am J Surg Pathol 16:885–895PubMedGoogle Scholar
Copyright information
© Springer-Verlag 2005